Synovus Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$42.7M Buy
230,188
+5,653
+3% +$969K 0.49% 33
2025
Q2
$34.3M Sell
224,535
-2,022
-0.9% -$311K 0.42% 37
2025
Q1
$37.6M Sell
226,557
-332
-0.1% -$51.9K 0.49% 30
2024
Q4
$32.8M Sell
226,889
-14,357
-6% -$2.22M 0.42% 33
2024
Q3
$39.1M Sell
241,246
-14,318
-6% -$2.28M 0.45% 33
2024
Q2
$37.4M Sell
255,564
-8,077
-3% -$1.2M 0.49% 29
2024
Q1
$41.7M Sell
263,641
-3,086
-1% -$491K 0.54% 26
2023
Q4
$41.8M Sell
266,727
-23,518
-8% -$3.61M 0.59% 26
2023
Q3
$45.2M Sell
290,245
-3,734
-1% -$616K 0.52% 36
2023
Q2
$48.7M Buy
293,979
+775
+0.3% +$125K 0.53% 34
2023
Q1
$45.4M Sell
293,204
-2,433
-0.8% -$393K 0.51% 38
2022
Q4
$52.2M Sell
295,637
-3,087
-1% -$533K 0.6% 29
2022
Q3
$48.8M Buy
298,724
+3,934
+1% +$666K 0.6% 28
2022
Q2
$52.4M Buy
294,790
+12,312
+4% +$2.19M 0.61% 28
2022
Q1
$50.1M Sell
282,478
-18,403
-6% -$3.13M 0.53% 27
2021
Q4
$51.5M Buy
300,881
+4,408
+1% +$722K 0.51% 29
2021
Q3
$47.8M Sell
296,473
-2,152
-0.7% -$367K 0.51% 29
2021
Q2
$49.1M Sell
298,625
-3,453
-1% -$572K 0.49% 30
2021
Q1
$49.6M Buy
302,078
+2,902
+1% +$470K 0.55% 26
2020
Q4
$47.1M Sell
299,176
-2,753
-0.9% -$406K 0.54% 27
2020
Q3
$44.9M Sell
301,929
-1,912
-0.6% -$283K 0.6% 27
2020
Q2
$42.7M Sell
303,841
-43,916
-13% -$6.4M 0.62% 25
2020
Q1
$45.6M Buy
347,757
+45,146
+15% +$6.41M 0.64% 28
2019
Q4
$44.1M Sell
302,611
-5,196
-2% -$705K 0.6% 28
2019
Q3
$39.8M Buy
307,807
+3,356
+1% +$442K 0.6% 26
2019
Q2
$42.4M Buy
304,451
+1,447
+0.5% +$200K 0.63% 24
2019
Q1
$42.3M Buy
303,004
+1,875
+0.6% +$251K 0.69% 25
2018
Q4
$38.9M Buy
301,129
+1,549
+0.5% +$216K 0.7% 23
2018
Q3
$41.4M Buy
299,580
+2,245
+0.8% +$298K 0.65% 24
2018
Q2
$36.1M Sell
297,335
-414
-0.1% -$51.6K 0.6% 25
2018
Q1
$38.2M Buy
297,749
+10,403
+4% +$1.41M 0.65% 26
2017
Q4
$40.1M Buy
287,346
+65
+0% +$9.05K 0.7% 25
2017
Q3
$37.4M Buy
287,281
+8,307
+3% +$1.1M 0.71% 23
2017
Q2
$36.9M Buy
278,974
+5,313
+2% +$678K 0.74% 20
2017
Q1
$34M Buy
273,661
+1,767
+0.6% +$211K 0.71% 22
2016
Q4
$31.4M Buy
271,894
+3,764
+1% +$435K 0.71% 23
2016
Q3
$31.7M Sell
268,130
-2,738
-1% -$332K 0.75% 21
2016
Q2
$32.8M Sell
270,868
-2,125
-0.8% -$241K 0.76% 23
2016
Q1
$29.6M Sell
272,993
-3,563
-1% -$369K 0.72% 22
2015
Q4
$28.4M Buy
276,556
+6,508
+2% +$654K 0.7% 24
2015
Q3
$25.2M Sell
270,048
-10,205
-4% -$987K 0.67% 24
2015
Q2
$27.3M Buy
280,253
+2,285
+0.8% +$229K 0.7% 22
2015
Q1
$28M Sell
277,968
-2,442
-0.9% -$248K 0.72% 23
2014
Q4
$29.3M Buy
280,410
+10,145
+4% +$1.07M 0.77% 21
2014
Q3
$28.8M Sell
270,265
-41,986
-13% -$4.35M 0.8% 17
2014
Q2
$32.6M Sell
312,251
-6,960
-2% -$703K 0.92% 17
2014
Q1
$31.4M Sell
319,211
-7,649
-2% -$709K 0.92% 16
2013
Q4
$29.9M Sell
326,860
-6,537
-2% -$602K 0.87% 17
2013
Q3
$28.9M Buy
333,397
+4,993
+2% +$448K 0.9% 16
2013
Q2
$28.2M Buy
+328,404
New +$27.9M 0.86% 21

Other funds holding JNJ

Synovus Financial's JNJ Position: Q3 2025 in Review

Synovus Financial increased its Johnson & Johnson (JNJ) stake by 2.5% in Q3 2025, buying an estimated $969K and bringing the position to 230,188 shares worth $42.7M. The position accounts for 0.49% of the portfolio, ranked #33.

Synovus Financial first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. The position peaked at $52.4M in Q2 2022. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Synovus Financial held 230,188 shares of Johnson & Johnson worth $42.7M as of Q3 2025.
  • Synovus Financial bought 5,653 Johnson & Johnson shares in Q3 2025, an estimated $969K.
  • Johnson & Johnson made up 0.49% of Synovus Financial's portfolio in Q3 2025, its #33 holding.
  • Synovus Financial first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
  • Synovus Financial's Johnson & Johnson position peaked at $52.4M in Q2 2022.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.